Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Spragg

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Advances in Experimental Medicine and Biology|January 1, 1983
Characterization of purified human latent kallikreinJ Spragg
Methods in Enzymology|January 1, 1988
Latent kallikrein from human urineJ Spragg
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1978
Specific functional and immunologic assay of plasma plasminogen in hereditary angioedema, in hereditary angioedema treated with tranexamic acid, and in normal subjectsJ Spragg
Nursing Management|October 1, 1990
CC and med/surg nurses: another studyJ Spragg
Molecular Immunology|November 1, 1988
The murine T-lymphocyte response to tyrosine-azobenzenearsonate. Characteristics of a low responder haplotype T-cell cloneJ Spragg, J W Goodman
Proceedings of the National Academy of Sciences of the United States of America|December 11, 2013
Antagonism of SAMHD1 is actively maintained in natural infections of simian immunodeficiency virusChelsea J Spragg, Michael Emerman
The Australian Journal of Experimental Biology and Medical Science|April 1, 1972
The occurrence of homogeneous antibodies and antigenic selection of kappa light chains to streptococcal carbohydrates in Monash rabbitsZ L Herd, J Spragg
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1971
the preparation of human kininogen. II. Further characterization of purified human kininogenJ Spragg, K F Austen
Biochemical Pharmacology|February 15, 1974
Preparation of human kininogen. 3. Enzymatic digestion and modificationJ Spragg, K F Austen
Hypertension (Dallas, Tex. : 1979)|May 1, 1985
Specificity of substrate analogue inhibitors of human urinary kallikreinH Okunishi, J Burton, J Spragg
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Advances in Experimental Medicine and Biology|January 1, 1983
Characterization of purified human latent kallikreinJ Spragg
Methods in Enzymology|January 1, 1988
Latent kallikrein from human urineJ Spragg
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1978
Specific functional and immunologic assay of plasma plasminogen in hereditary angioedema, in hereditary angioedema treated with tranexamic acid, and in normal subjectsJ Spragg
Nursing Management|October 1, 1990
CC and med/surg nurses: another studyJ Spragg
Molecular Immunology|November 1, 1988
The murine T-lymphocyte response to tyrosine-azobenzenearsonate. Characteristics of a low responder haplotype T-cell cloneJ Spragg, J W Goodman
Proceedings of the National Academy of Sciences of the United States of America|December 11, 2013
Antagonism of SAMHD1 is actively maintained in natural infections of simian immunodeficiency virusChelsea J Spragg, Michael Emerman
The Australian Journal of Experimental Biology and Medical Science|April 1, 1972
The occurrence of homogeneous antibodies and antigenic selection of kappa light chains to streptococcal carbohydrates in Monash rabbitsZ L Herd, J Spragg
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1971
the preparation of human kininogen. II. Further characterization of purified human kininogenJ Spragg, K F Austen
Biochemical Pharmacology|February 15, 1974
Preparation of human kininogen. 3. Enzymatic digestion and modificationJ Spragg, K F Austen
Hypertension (Dallas, Tex. : 1979)|May 1, 1985
Specificity of substrate analogue inhibitors of human urinary kallikreinH Okunishi, J Burton, J Spragg
Pageof 6